Clinical characteristic | NO. of patients | p value | |
---|---|---|---|
ATG4C low expression | ATG4C high expression | ||
NO. of cases | 487 | 488 | Â |
Age (years) | |||
  ≥ 55 | 297 (60.99%) | 249 (51.02%) | 0.002 |
  < 55 | 190 (39.01%) | 239 (48.98%) | |
Gender | |||
 Male | 279 (57.29%) | 294 (60.25%) | 0.348 |
 Female | 208 (42.71%) | 194 (39.75%) | |
WHO grade | |||
 II | 121 (24.85%) | 77 (15.78%) | 0.000 |
 III | 120 (24.64%) | 96 (19.67%) | |
 IV | 246 (50.51%) | 315 (64.55%) | |
IDH status | |||
 Wild | 185 (37.99%) | 130 (26.64%) | 0.000 |
 Mutant | 242 (49.69%) | 298 (61.07%) | |
 Undefined | 60 (12.32%) | 60 (12.30%) | |
MGMT status | |||
 Unmethylated | 110 (22.59%) | 224 (45.90%) | 0.000 |
 Methylated | 290 (59.55%) | 170 (34.84%) | |
 Undefined | 87 (17.86%) | 94 (19.26%) |